Ledger.Open graph →
SEC Form D · filed October 15, 2019

Crimson BioPharm Inc

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BROOKLINE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Thomas Roberts · NEWPORT BEACH, CADirectorJean Zhao · Brookline, MADirectorHaiying Peng · Brookline, MAExec · DirectorJean Zhao · Brookline, MADirectorHaiying Peng · Brookline, MAExec · DirectorThomas Roberts · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗